GO:0004177 | aminopeptidase activity | 1.98e-04 | 1.00e+00 | 6.539 | 2 | 3 | 14 |
GO:0004832 | valine-tRNA ligase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.79e-03 | 1.00e+00 | 4.646 | 2 | 8 | 52 |
GO:0033688 | regulation of osteoblast proliferation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0019784 | NEDD8-specific protease activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0016032 | viral process | 3.38e-03 | 1.00e+00 | 2.605 | 4 | 30 | 428 |
GO:1901315 | negative regulation of histone H2A K63-linked ubiquitination | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 3 |
GO:0004301 | epoxide hydrolase activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0070006 | metalloaminopeptidase activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0001649 | osteoblast differentiation | 5.58e-03 | 1.00e+00 | 4.137 | 2 | 5 | 74 |
GO:0036089 | cleavage furrow formation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0033503 | HULC complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0010815 | bradykinin catabolic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0006508 | proteolysis | 6.99e-03 | 1.00e+00 | 2.887 | 3 | 11 | 264 |
GO:0010467 | gene expression | 7.49e-03 | 1.00e+00 | 2.283 | 4 | 49 | 535 |
GO:0008235 | metalloexopeptidase activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:2000780 | negative regulation of double-strand break repair | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0043931 | ossification involved in bone maturation | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0005672 | transcription factor TFIIA complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0005654 | nucleoplasm | 8.04e-03 | 1.00e+00 | 1.894 | 5 | 68 | 876 |
GO:0050847 | progesterone receptor signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 6 |
GO:0043297 | apical junction assembly | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0035615 | clathrin adaptor activity | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0033523 | histone H2B ubiquitination | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0090307 | spindle assembly involved in mitosis | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 8 |
GO:0008242 | omega peptidase activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010390 | histone monoubiquitination | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0043296 | apical junction complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0030122 | AP-2 adaptor complex | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0030100 | regulation of endocytosis | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0048268 | clathrin coat assembly | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0072583 | clathrin-mediated endocytosis | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0050919 | negative chemotaxis | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0019370 | leukotriene biosynthetic process | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 15 | 128 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 4 | 11 |
GO:0017025 | TBP-class protein binding | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 1 | 12 |
GO:0031625 | ubiquitin protein ligase binding | 1.85e-02 | 1.00e+00 | 3.238 | 2 | 7 | 138 |
GO:0017075 | syntaxin-1 binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0050772 | positive regulation of axonogenesis | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0071108 | protein K48-linked deubiquitination | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 15 |
GO:0032467 | positive regulation of cytokinesis | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 16 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.46e-02 | 1.00e+00 | 3.016 | 2 | 18 | 161 |
GO:0042803 | protein homodimerization activity | 2.57e-02 | 1.00e+00 | 2.190 | 3 | 13 | 428 |
GO:0008380 | RNA splicing | 2.58e-02 | 1.00e+00 | 2.980 | 2 | 21 | 165 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0006378 | mRNA polyadenylation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.88e-02 | 1.00e+00 | 5.099 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0050690 | regulation of defense response to virus by virus | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 22 |
GO:0005856 | cytoskeleton | 3.35e-02 | 1.00e+00 | 2.777 | 2 | 8 | 190 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 2 | 23 |
GO:0002376 | immune system process | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 2 | 23 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 1 | 23 |
GO:0005525 | GTP binding | 3.58e-02 | 1.00e+00 | 2.724 | 2 | 12 | 197 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 24 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 3.65e-02 | 1.00e+00 | 2.710 | 2 | 8 | 199 |
GO:0006281 | DNA repair | 3.78e-02 | 1.00e+00 | 2.681 | 2 | 24 | 203 |
GO:0030145 | manganese ion binding | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 26 |
GO:0051496 | positive regulation of stress fiber assembly | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 27 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 28 |
GO:0030054 | cell junction | 4.30e-02 | 1.00e+00 | 2.578 | 2 | 5 | 218 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0043130 | ubiquitin binding | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 30 |
GO:0032154 | cleavage furrow | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 3 | 30 |
GO:0007411 | axon guidance | 5.00e-02 | 1.00e+00 | 2.458 | 2 | 8 | 237 |
GO:0021762 | substantia nigra development | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0007254 | JNK cascade | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0008565 | protein transporter activity | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 35 |
GO:0050434 | positive regulation of viral transcription | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 35 |
GO:0030334 | regulation of cell migration | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 36 |
GO:0030666 | endocytic vesicle membrane | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 36 |
GO:0006396 | RNA processing | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 6 | 40 |
GO:0004843 | ubiquitin-specific protease activity | 6.84e-02 | 1.00e+00 | 3.823 | 1 | 2 | 46 |
GO:0032481 | positive regulation of type I interferon production | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 48 |
GO:0000151 | ubiquitin ligase complex | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 4 | 48 |
GO:0005739 | mitochondrion | 7.58e-02 | 1.00e+00 | 1.567 | 3 | 32 | 659 |
GO:0006289 | nucleotide-excision repair | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 3 | 53 |
GO:0005737 | cytoplasm | 8.10e-02 | 1.00e+00 | 0.791 | 7 | 127 | 2633 |
GO:0042826 | histone deacetylase binding | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 5 | 61 |
GO:0070062 | extracellular vesicular exosome | 9.22e-02 | 1.00e+00 | 0.988 | 5 | 51 | 1641 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 64 |
GO:0005923 | tight junction | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 2 | 64 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.47e-02 | 1.00e+00 | 1.933 | 2 | 23 | 341 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 9.82e-02 | 1.00e+00 | 3.280 | 1 | 5 | 67 |
GO:0030308 | negative regulation of cell growth | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 3 | 70 |
GO:0016020 | membrane | 1.04e-01 | 1.00e+00 | 1.109 | 4 | 56 | 1207 |
GO:0030496 | midbody | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 6 | 73 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 6 | 77 |
GO:0030529 | ribonucleoprotein complex | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 5 | 82 |
GO:0005215 | transporter activity | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 2 | 83 |
GO:0005829 | cytosol | 1.23e-01 | 1.00e+00 | 0.865 | 5 | 88 | 1787 |
GO:0030027 | lamellipodium | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 3 | 88 |
GO:0006886 | intracellular protein transport | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 2 | 89 |
GO:0005515 | protein binding | 1.29e-01 | 1.00e+00 | 0.507 | 9 | 198 | 4124 |
GO:0030036 | actin cytoskeleton organization | 1.30e-01 | 1.00e+00 | 2.855 | 1 | 4 | 90 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 6 | 92 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.52e-01 | 1.00e+00 | 2.605 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.54e-01 | 1.00e+00 | 2.592 | 1 | 2 | 108 |
GO:0042981 | regulation of apoptotic process | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.60e-01 | 1.00e+00 | 2.526 | 1 | 6 | 113 |
GO:0007049 | cell cycle | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 7 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 1.71e-01 | 1.00e+00 | 2.428 | 1 | 11 | 121 |
GO:0006184 | GTP catabolic process | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 7 | 130 |
GO:0032403 | protein complex binding | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 5 | 130 |
GO:0030168 | platelet activation | 1.96e-01 | 1.00e+00 | 2.207 | 1 | 5 | 141 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 1.97e-01 | 1.00e+00 | 2.197 | 1 | 5 | 142 |
GO:0044212 | transcription regulatory region DNA binding | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 13 | 143 |
GO:0005634 | nucleus | 2.01e-01 | 1.00e+00 | 0.489 | 7 | 158 | 3246 |
GO:0016874 | ligase activity | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 11 | 146 |
GO:0007264 | small GTPase mediated signal transduction | 2.37e-01 | 1.00e+00 | 1.904 | 1 | 8 | 174 |
GO:0004842 | ubiquitin-protein transferase activity | 2.42e-01 | 1.00e+00 | 1.863 | 1 | 17 | 179 |
GO:0007165 | signal transduction | 2.45e-01 | 1.00e+00 | 1.075 | 2 | 24 | 618 |
GO:0003713 | transcription coactivator activity | 2.48e-01 | 1.00e+00 | 1.823 | 1 | 21 | 184 |
GO:0005743 | mitochondrial inner membrane | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 9 | 197 |
GO:0008134 | transcription factor binding | 2.77e-01 | 1.00e+00 | 1.639 | 1 | 10 | 209 |
GO:0019899 | enzyme binding | 2.78e-01 | 1.00e+00 | 1.632 | 1 | 7 | 210 |
GO:0007268 | synaptic transmission | 2.83e-01 | 1.00e+00 | 1.605 | 1 | 7 | 214 |
GO:0005886 | plasma membrane | 2.88e-01 | 1.00e+00 | 0.546 | 4 | 46 | 1784 |
GO:0008270 | zinc ion binding | 3.09e-01 | 1.00e+00 | 0.841 | 2 | 39 | 727 |
GO:0007155 | cell adhesion | 3.16e-01 | 1.00e+00 | 1.416 | 1 | 8 | 244 |
GO:0003723 | RNA binding | 3.19e-01 | 1.00e+00 | 1.398 | 1 | 22 | 247 |
GO:0046982 | protein heterodimerization activity | 3.38e-01 | 1.00e+00 | 1.297 | 1 | 11 | 265 |
GO:0008285 | negative regulation of cell proliferation | 3.51e-01 | 1.00e+00 | 1.233 | 1 | 11 | 277 |
GO:0005925 | focal adhesion | 3.56e-01 | 1.00e+00 | 1.207 | 1 | 14 | 282 |
GO:0009986 | cell surface | 3.65e-01 | 1.00e+00 | 1.162 | 1 | 5 | 291 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.91e-01 | 1.00e+00 | 1.038 | 1 | 17 | 317 |
GO:0005524 | ATP binding | 4.04e-01 | 1.00e+00 | 0.546 | 2 | 37 | 892 |
GO:0007596 | blood coagulation | 4.12e-01 | 1.00e+00 | 0.941 | 1 | 13 | 339 |
GO:0003677 | DNA binding | 4.35e-01 | 1.00e+00 | 0.459 | 2 | 52 | 947 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.46e-01 | 1.00e+00 | 0.788 | 1 | 21 | 377 |
GO:0045087 | innate immune response | 5.09e-01 | 1.00e+00 | 0.526 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.12e-01 | 1.00e+00 | 0.514 | 1 | 29 | 456 |
GO:0005730 | nucleolus | 5.74e-01 | 1.00e+00 | 0.097 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.98e-01 | 1.00e+00 | 0.179 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.41e-01 | 1.00e+00 | 0.016 | 1 | 29 | 644 |
GO:0005615 | extracellular space | 6.45e-01 | 1.00e+00 | 0.000 | 1 | 15 | 651 |
GO:0005576 | extracellular region | 6.52e-01 | 1.00e+00 | -0.026 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 6.81e-01 | 1.00e+00 | -0.135 | 1 | 31 | 715 |
GO:0044822 | poly(A) RNA binding | 7.22e-01 | 1.00e+00 | -0.296 | 1 | 45 | 799 |